| Industry
Industry name |
Pharmaceuticals |
| Variance
Full Year Net Profit Variance |
56 |
| Equity
Latest Equity |
94 |
| Face Value
Latest Face Value |
1 |
| Reserves
Total Reserve |
320.99 |
| Dividend
Full Year Dividend % |
0 |
| Sales Turnover
Full Year Net Sales |
489.17 |
| Net Profit
Full Year Net Profit |
76.41 |
| Full Year CPS
Full Year Cash Per Share |
0.9 |
| Earning Per Share
Full Year Earning Per Share |
0.8 |
| Quarter CPS
Latest quarter Cash Per Share |
0 |
| Latest Quarter Date
Latest Quarter Yrc |
Jun 1, 2026 |
| Latest Quarter Sales
Latest Quarter Net Sales |
125.53 |
| Previous EPS
Previous earnings per share |
0 |
| Book Value
Book value |
4.4 |
| Networth
Full Year Return on Networth |
15.68 |
| Price/Book Value
Price to Book value |
3.409091 |
| Yearly PE ratio
Full Year Price to Earning per share |
18.5 |
| Yearly PC ratio
Full Year Price to Cash Per Share |
17 |
| Bse value
BSE Value in lakhs |
85.12 |
| Nse value
NSE Value in lakhs |
614.94 |
| High
52 week high |
19 |
| Low
52 week low |
10 |
| Price
NSE Current market price |
15 |
| CPM
Current market price |
15 |
| Market cap
BSE / NSE Market Cap |
1429.74 |
| Net profit
Latest Quarter Net Profit |
24.85 |
| Net profit variance
Latest Quarter Net Profit variance |
58 |
| Result year
Trailing latest month |
Jun 1, 2026 |
| TTM Sales
Trailing Twelve 12 month Net Sales |
328.32 |
| TTM OP
Trailing Twelve 12 month Operating Profit |
38.41 |
| TTM OPM
Trailing Twelve 12 month Operating Profit Margin |
11.7 |
| TTM GP
Trailing Twelve 12 month Gross Profit |
119.81 |
| TTM GPM
Trailing Twelve 12 month Gross Profit Margin |
24.07 |
| TTM NP
Trailing Twelve 12 month Net Profit |
33.16 |
| TTM NPV
Trailing Twelve 12 month Net Profit Variane |
48.7 |
| TTM EPS
Trailing Twelve 12 month EPS |
0.91 |
| TTM PE
Trailing Twelve 12 month PE |
16.71 |
| TTM CPS
Trailing Twelve 12 month CPS |
0 |
| Month CPS
Month Cash Per Share |
0 |
| TTM Depreciation
Trailing Twelve 12 month Depreciation |
5.34 |
| Equity
Latest Equity |
94 |
| LTP
Latest Price (BSE/NSE) |
15 |
| Gross block
Latest Gross Block |
192.96 |
| Loans
Total loans |
0 |
| Advances
Latest Advances for Banks |
0 |
| Net profit asset
Latest Assets |
0 |
| Year OPM
Full Year Operating Profit Margin |
15.8 |
| Year GPM
Full Year Gross Profit Margin |
22 |
| Quarter OPM
Latest quater Operation Profit Margin |
20.9 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| + Sales | 102 | 128 | 149 | 117 | 122 | 115 | 135 | 126 |
| YOY Sales Growth % | 60% | 96% | 100% | 34% | 19% | -10% | -9% | 7% |
| Gross Sales | 102 | 128 | 149 | 117 | 122 | 115 | 135 | 126 |
| + Expenses | 90 | 113 | 131 | 101 | 103 | 94 | 113 | 99 |
| Material Cost % | 82% | 57% | 51% | 56% | 31% | 43% | 53% | 56% |
| Raw Material Cost | 69 | 76 | 80 | 60 | 46 | 47 | 67 | 59 |
| Change in Inventory | 15 | -3 | -4 | 6 | -9 | 2 | 5 | 11 |
| Manufacturing Cost % | 12% | 10% | 11% | 14% | 13% | 13% | 10% | 13% |
| Employee Cost % | 12% | 11% | 10% | 14% | 14% | 15% | 13% | 14% |
| Other Cost % | -18% | 11% | 17% | 3% | 27% | 10% | 8% | -3% |
| Raw Materials % | 67% | 60% | 54% | 51% | 38% | 41% | 50% | 47% |
| Purchase of Finished Goods % | 12% | 6% | 11% | 13% | 13% | 14% | 15% | 15% |
| Stock Adjustments % | -15% | 2% | 3% | -5% | 7% | -2% | -3% | -9% |
| Other Manufacturing Expenses % | 12% | 10% | 11% | 14% | 13% | 13% | 10% | 13% |
| Operating Profit | 12 | 15 | 18 | 16 | 18 | 21 | 22 | 26 |
| OPM % | 12% | 12% | 12% | 14% | 15% | 18% | 16% | 21% |
| + Other Income | 4 | 4 | 7 | 6 | 5 | 6 | 15 | 8 |
| Miscellaneous Income | 4 | 4 | 7 | 6 | 5 | 6 | 15 | 8 |
| Exceptional Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 15 | 17 | 23 | 20 | 22 | 25 | 34 | 32 |
| + Tax % | 25% | 25% | 24% | 22% | 25% | 25% | 25% | 23% |
| Current Tax | 4 | 4 | 5 | 4 | 5 | 6 | 7 | 7 |
| Deferred Tax | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
| + Net Profit | 11 | 13 | 18 | 16 | 17 | 19 | 25 | 25 |
| Extraordinary Income / Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Item | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit After Minority Interest | 11 | 13 | 18 | 16 | 17 | 19 | 25 | 25 |
| EPS in Rs | 0.16 | 0.14 | 0.19 | 0.21 | 0.18 | 0.20 | 0.27 | 0.26 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Sales | 186 | 185 | 159 | 187 | 206 | 245 | 220 | 224 | 263 | 465 |
| Sales Growth % | -0% | -14% | 18% | 10% | 19% | -10% | 2% | 17% | 77% | |
| Gross Sales | 182 | 185 | 159 | 187 | 206 | 245 | 220 | 224 | 263 | 466 |
| Excise Duty | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Income | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Expenses | 169 | 168 | 147 | 175 | 189 | 207 | 200 | 205 | 234 | 411 |
| Material Cost % | 71% | 69% | 69% | 73% | 74% | 66% | 64% | 63% | 60% | 66% |
| Raw Material Cost | 135 | 123 | 110 | 137 | 155 | 166 | 137 | 142 | 159 | 318 |
| Change in Inventory | -4 | 5 | -1 | -1 | -4 | -4 | 3 | 0 | -2 | -11 |
| Manufacturing Cost % | 2% | 2% | 3% | 3% | 3% | 2% | 3% | 4% | 3% | 2% |
| Employee Cost % | 7% | 8% | 9% | 8% | 8% | 7% | 9% | 11% | 13% | 11% |
| Other Cost % | 10% | 12% | 12% | 10% | 8% | 9% | 15% | 13% | 13% | 10% |
| Raw Materials % | 73% | 67% | 69% | 73% | 76% | 68% | 62% | 63% | 60% | 68% |
| Purchase of Finished Goods % | 36% | 29% | 20% | 29% | 29% | 27% | 18% | 19% | 10% | 9% |
| Stock Adjustments % | 2% | -3% | 0% | 1% | 2% | 2% | -2% | 0% | 1% | 2% |
| Power & Fuel % | 1% | 2% | 2% | 2% | 2% | 2% | 2% | 2% | 2% | 1% |
| Other Manufacturing Expenses % | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Selling & Administration % | 9% | 11% | 10% | 9% | 7% | 8% | 14% | 12% | 12% | 9% |
| Miscellaneous Expenses % | 0% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Operating Profit | 17 | 17 | 12 | 12 | 17 | 38 | 20 | 20 | 30 | 54 |
| OPM % | 9% | 9% | 7% | 6% | 8% | 15% | 9% | 9% | 11% | 12% |
| + Other Income | 3 | 3 | 4 | 5 | 5 | 7 | 12 | 15 | 14 | 17 |
| Miscellaneous Income | 3 | 3 | 4 | 5 | 5 | 7 | 12 | 15 | 14 | 16 |
| Exceptional Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 3 | 5 | 1 |
| Depreciation | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 |
| Profit before tax | 16 | 16 | 12 | 13 | 17 | 41 | 26 | 27 | 34 | 66 |
| + Tax % | 36% | 33% | 28% | 12% | 18% | 28% | 24% | 24% | 25% | 25% |
| Current Tax | 5 | 4 | 3 | 3 | 4 | 11 | 6 | 7 | 8 | 15 |
| Deferred Tax | 0 | 1 | 0 | -2 | -1 | 0 | 0 | 0 | 1 | 1 |
| + Net Profit | 10 | 11 | 9 | 11 | 14 | 29 | 20 | 20 | 25 | 49 |
| Profit Growth % | 3% | -19% | 28% | 29% | 105% | -32% | 1% | 26% | 95% | |
| Extraordinary Income / Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Item | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit After Minority Interest | 10 | 11 | 0 | 0 | 0 | 0 | 20 | 20 | 25 | 49 |
| EPS in Rs | 0.13 | 0.13 | 0.23 | 0.21 | 0.27 | 0.53 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 78 | 78 | 78 | 78 | 78 | 79 | 86 | 94 | 94 | 94 |
| Reserves | 31 | 39 | 44 | 55 | 68 | 109 | 136 | 162 | 194 | 248 |
| + Borrowings | 6 | 12 | 12 | 9 | 2 | 62 | 58 | 83 | 72 | 5 |
| Secured Borrowings | 6 | 6 | 8 | 9 | 2 | 62 | 58 | 83 | 72 | 5 |
| Unsecured Borrowings | 0 | 6 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Other Liabilities | 61 | 50 | 37 | 32 | 33 | 42 | 28 | 39 | 44 | 67 |
| Current Liabilities | 61 | 50 | 35 | 30 | 30 | 39 | 26 | 35 | 40 | 62 |
| Provisions | 4 | 5 | 2 | 2 | 2 | 2 | 4 | 3 | 4 | 4 |
| Equity Share Warrants | 0 | 0 | 0 | 0 | 0 | 10 | 5 | 0 | 0 | 0 |
| Other liability items | 0 | 1 | 2 | 2 | 3 | 3 | 3 | 4 | 5 | 6 |
| Total Liabilities | 175 | 180 | 171 | 173 | 181 | 292 | 308 | 378 | 405 | 413 |
| + Fixed Assets | 46 | 55 | 89 | 89 | 93 | 91 | 94 | 91 | 120 | 125 |
| Gross Block | 82 | 92 | 129 | 132 | 140 | 142 | 148 | 149 | 183 | 193 |
| Accumulated Depreciation | 37 | 37 | 40 | 43 | 47 | 51 | 54 | 59 | 63 | 68 |
| CWIP | 5 | 0 | 1 | 0 | 0 | 0 | 6 | 26 | 0 | 0 |
| Investments | 23 | 36 | 2 | 2 | 1 | 11 | 43 | 64 | 66 | 93 |
| + Other Assets | 101 | 89 | 79 | 83 | 87 | 189 | 165 | 197 | 219 | 196 |
| Inventories | 15 | 10 | 11 | 14 | 16 | 23 | 20 | 21 | 21 | 41 |
| Trade receivables | 46 | 46 | 38 | 41 | 43 | 75 | 68 | 76 | 103 | 108 |
| Cash Equivalents | 6 | 7 | 6 | 8 | 9 | 64 | 0 | 9 | 68 | 1 |
| Loans n Advances | 19 | 21 | 24 | 16 | 18 | 19 | 12 | 15 | 20 | 32 |
| Other asset items | 15 | 6 | 1 | 4 | 0 | 8 | 66 | 77 | 7 | 14 |
| Total Assets | 175 | 180 | 171 | 173 | 181 | 292 | 308 | 378 | 405 | 413 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Cash from Operating Activity | 24 | 14 | -2 | 4 | 6 | -2 | 16 | 11 | -6 | 23 |
| Profit from Operations | 17 | 17 | 19 | 20 | 30 | 54 | ||||
| Working Capital Changes | 12 | 1 | 4 | -3 | -28 | -16 | ||||
| Profit Before Tax & Extraordinary Items | 16 | 16 | 12 | 13 | 17 | 41 | 26 | 27 | 34 | 66 |
| Depreciation | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 4 | 5 | 5 |
| Interest (Net) | -1 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 4 | 1 |
| Profit / Loss on Sale of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Provisions & Write-offs (Net) | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| Receivables | -15 | 0 | 8 | -4 | -2 | -31 | 7 | -8 | -28 | -4 |
| Inventories | -5 | 5 | -1 | -3 | -2 | -6 | 3 | -2 | 0 | -20 |
| Trade Payables | 27 | -15 | -10 | -1 | -1 | 9 | -16 | 7 | 4 | 19 |
| Loans & Advances | 2 | 8 | 1 | -1 | 1 | 0 | -2 | 1 | -2 | -1 |
| Change in Borrowing | 0 | 0 | 0 | -4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Direct Taxes Paid | -5 | -4 | -3 | -3 | -4 | -11 | -6 | -7 | -8 | -15 |
| Extraordinary Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Cash from Investing Activity | -23 | -18 | -2 | 2 | 2 | -75 | -27 | -45 | 83 | -18 |
| Purchase of Fixed Assets | -3 | -13 | -7 | 0 | -2 | -3 | -11 | -21 | -8 | -10 |
| Sale of Fixed Assets | 0 | 1 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | -17 | -13 | -2 | -9 | -7 | 0 | -30 | -19 | 0 | -22 |
| Sale of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 |
| Investment Income | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Received | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Received | -5 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others | 0 | 0 | 6 | 5 | 10 | -73 | 15 | -5 | 86 | 14 |
| + Cash from Financing Activity | -2 | 5 | -2 | 0 | -7 | 72 | 8 | 35 | -15 | -68 |
| Proceeds from Issue of Shares | 0 | 0 | 0 | 0 | 0 | 12 | 14 | 0 | 0 | 0 |
| Proceeds from Other Long-Term Borrowings | 0 | 0 | 0 | 0 | 0 | 60 | 0 | 25 | 0 | 0 |
| Proceeds from Short-Term Borrowings | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Repayment of Long-Term Borrowings | 0 | 0 | 0 | 0 | -7 | 0 | -4 | 0 | -11 | -68 |
| Repayment of Short-Term Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Paid | -2 | -2 | -2 | 0 | 0 | 0 | 0 | -3 | 0 | 0 |
| Interest Paid | 0 | 0 | -1 | -3 | -4 | -1 | ||||
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 1 | 1 |
| Net Cash Flow | -1 | 1 | -6 | 7 | 1 | -5 | -2 | 1 | 63 | -63 |